JUN 08, 2021 6:00 AM PDT

Fueling the Immune System's Killers

WRITTEN BY: Tara Fernandes

There’s a group of “killers” protecting your body against infections and eliminating potentially cancerous tissues—natural killers, or NK cells, are first responders of the innate immune system. 

"There's a lot of interest right now in NK cells as a potential target of immunotherapy," says Joseph Sun, an NK cell expert leading studies into the complex physiology of these immune fighters. "The more we can understand what drives these cells, the better we can program them to fight disease."

Sun and colleagues were interested in NK metabolism, specifically whether these cells rely on aerobic glycolysis to fuel their protective activities, like their T cell counterparts. Insights into how NK cells are powered would help understand the mechanics of how these cells eliminate pathogens and tumors.

The team used an animal model to examine the biology of NK cells in an in vivo setting and found that NK cells go through a spike in aerobic glycolysis about five days before the same surge occurs in T cells.

These findings line up with the theory that NK cells are a critical part of mounting a rapid, early response to infections, insights that can be used towards developing more potent NK cell-based immunotherapies for cancer patients.

"If you're growing these cells in a dish and you push them to divide too rapidly, they may not have as much potential to undergo aerobic glycolysis when you put them into a patient," explained Sam Sheppard, another researcher on Sun’s team.

According to the scientists, researchers creating protocols for NK cell clinical trials should keep this in mind, finding a “sweet spot” between promoting the replication of NK cells for administration into the patient and preserving their energy to destroy tumors once inside the body.

 




Sources: Memorial Sloan Kettering Cancer Center, Cell Reports.

About the Author
PhD
Interested in health technology and innovation.
You May Also Like
AUG 23, 2022
Clinical & Molecular DX
By Targeting the Cause of the Disease, a Potential Long-Term Treatment for Asthma is Found
AUG 23, 2022
By Targeting the Cause of the Disease, a Potential Long-Term Treatment for Asthma is Found
Asthma is a disease that affects the lungs, causing symptoms of wheezing, tightness in the chest, and shortness of breat ...
SEP 23, 2022
Neuroscience
'The Life of her Mind' Episode 1: Dr. Alice Dreger
SEP 23, 2022
'The Life of her Mind' Episode 1: Dr. Alice Dreger
The Life of Her Mind is a new video series focusing on the lives, perspectives, career pathways, and research of women w ...
OCT 18, 2022
Immunology
T Cell Deficiency Leaves Some Vulnerable to Infection
OCT 18, 2022
T Cell Deficiency Leaves Some Vulnerable to Infection
The mycobacterium avium complex (MAC) bacteria can be found everywhere, so almost everyone breathes some of it in occasi ...
NOV 01, 2022
Cardiology
Autoimmune Disorders Increase Cardiovascular Risk
NOV 01, 2022
Autoimmune Disorders Increase Cardiovascular Risk
People with autoimmune disorders are significantly more likely to develop heart disease compared to the general populati ...
NOV 03, 2022
Clinical & Molecular DX
Co-Infections of COVID-19 and the Flu were Common Last Winter, Researchers Find
NOV 03, 2022
Co-Infections of COVID-19 and the Flu were Common Last Winter, Researchers Find
Infections of SARS-CoV-2, or COVID-19, do not always occur on their own. A COVID-19 infection can occur at the same time ...
NOV 22, 2022
Microbiology
Flu Killed Mice Eating a Processed Diet, but Spared Those on Grains
NOV 22, 2022
Flu Killed Mice Eating a Processed Diet, but Spared Those on Grains
When researchers have studied infections in animal models, they have typically focused on the pathogen and the host. But ...
Loading Comments...